Druggability Technologies Holdings, Ltd – Trademark Portfolio
Entity Type: 16
Druggability Technologies Holdings, Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TAVANTA THERAPEUTICS. The owner is based in Dublin.
70 Sir John Rogerson's Quay
Dublin 2 , IE
Showing of trademarks Trademarks
Trademark Classifications
Druggability Technologies Holdings, Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Druggability Technologies Holdings, Ltd have?
Druggability Technologies Holdings, Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Druggability Technologies Holdings, Ltd file in?
Druggability Technologies Holdings, Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Druggability Technologies Holdings, Ltd's most well-known trademarks?
Druggability Technologies Holdings, Ltd's registered trademark portfolio includes well-known marks such as TAVANTA THERAPEUTICS. These are among 1 currently registered trademark in the portfolio.
What is Druggability Technologies Holdings, Ltd's trademark registration success rate?
Druggability Technologies Holdings, Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.